Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07448831 |
| Title | A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma. (NeoSenti) |
| Acronym | NeoSenti |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Universitair Ziekenhuis Brussel |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UZ Brussel | RECRUITING | Jette | Brussels Capital | 1090 | Belgium | Details |